In Brief This Week: Exiqon; Roche 454 Life Sciences; Center for Medicine in the Public Interest | GenomeWeb

NEW YORK (GenomeWeb News) – Exiqon unveiled a new grant program today for researchers at academic and non-profit institutions in North America conducting microRNA studies. The firm said that the grant program has been established with internal seed funding of $25,000. It did not say how many awards it would grant, but said that recipients may use the awards for purchasing Exiqon microRNA products or services. Applications are due June 15, with recipients announced no later than July 1, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.